BCGP Recert: Risk versus benefit of SGLT2i's in Older Adults
Tracking # 20-1223982
$99999.00
There are no ratings for this course
Learn more Educator AMERICAN PHARMACISTS ASSOCIATION
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
0202-9999-24-262-H01-P - This interactive BCGP Recertification case study will provide pharmacists with the opportunity to apply knowledge related to pharmacotherapy management of Alzheimer Disease in older adults. Pharmacists will work through interventions related to appropriate drug therapy selection in a patient with Alzheimer Disease and construct a plan to optimize drug therapy and monitor for therapeutic outcomes.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
1.5h
General